Read the full 2022 Impact Report.
The International Myeloma Foundation's (IMF) Impact in 2022 and the Future of the IMF
IMF President and CEO Yelak Biru Reflects on the Impact of the IMF in 2022 and Share His Vision for the Future.
Because of your support, the International Myeloma Foundation (IMF) made huge strides in myeloma research, education, support, and advocacy in 2022.
Previous Post
Are mass spectrometry and next-generation flow useful tests to evaluate minimal residual disease (MRD)?
Next Post
Is there a new highly sensitive blood test to detect minimal residual disease?




